{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:59:32Z","timestamp":1774619972285,"version":"3.50.1"},"reference-count":58,"publisher":"Impact Journals, LLC","issue":"31","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,10,13]]},"DOI":"10.18632\/oncotarget.5567","type":"journal-article","created":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T21:54:23Z","timestamp":1443563663000},"page":"31805-31819","source":"Crossref","is-referenced-by-count":25,"title":["Mutation of cysteine 46 in IKK-beta increases inflammatory responses"],"prefix":"10.18632","volume":"6","author":[{"given":"Ting","family":"Li","sequence":"first","affiliation":[{"name":"State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent Kam","family":"Wai Wong","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi Hong","family":"Jiang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shui Ping","family":"Jiang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[{"name":"Shum Yiu Foon Shum Bik Chuen Memorial Centre for Cancer and Inflammation Research, School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting Yu","family":"Wang","sequence":"additional","affiliation":[{"name":"Shum Yiu Foon Shum Bik Chuen Memorial Centre for Cancer and Inflammation Research, School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao Jun","family":"Yao","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao Hui","family":"Su","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng Gen","family":"Yan","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine Lai-Han","family":"Leung","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao Qin","family":"Yi","sequence":"additional","affiliation":[{"name":"Shum Yiu Foon Shum Bik Chuen Memorial Centre for Cancer and Inflammation Research, School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuen Fan","family":"Wong","sequence":"additional","affiliation":[{"name":"Shum Yiu Foon Shum Bik Chuen Memorial Centre for Cancer and Inflammation Research, School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Zhou","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2015,9,10]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1038\/480S100a","article-title":"Perspective: The clinical trial barriers","volume":"480","author":"Tian","year":"2011","journal-title":"Nature"},{"key":"2","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nm1254","article-title":"Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice","volume":"11","author":"Fusco","year":"2005","journal-title":"Nat Med"},{"key":"3","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nm.2713","article-title":"A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer","volume":"18","author":"Huang","year":"2012","journal-title":"Nat Med"},{"key":"4","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nm.2130","article-title":"A CD8+ T cell transcription signature predicts prognosis in autoimmune disease","volume":"16","author":"Chaudhry","year":"2010","journal-title":"Nat Med"},{"key":"5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nm.3462","article-title":"In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease","volume":"20","author":"Heimke-Brinck","year":"2014","journal-title":"Nat Med"},{"key":"6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature04870","article-title":"Nuclear factor-kappaB in cancer development and progression","volume":"441","author":"Karin","year":"2006","journal-title":"Nature"},{"key":"7","first-page":"1275","article-title":"IKK-related genetic diseases: probing NF-kappaB functions in humans and other matters","volume":"72","author":"Courtois","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"8","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nri1703","article-title":"NF-kappaB: linking inflammation and immunity to cancer development and progression","volume":"5","author":"Greten","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nm1185","article-title":"IKK-beta links inflammation to obesity-induced insulin resistance","volume":"11","author":"Karin","year":"2005","journal-title":"Nat Med"},{"key":"10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm1166","article-title":"Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB","volume":"11","author":"Shoelson","year":"2005","journal-title":"Nat Med"},{"key":"11","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/S0960-894X(03)00408-6","article-title":"Novel IKK inhibitors: beta-carbolines","volume":"13","author":"Adams","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"12","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1002\/art.11131","article-title":"A highly selective inhibitor of I kappa B kinase, BMS-345541, blocks both joint inflammation and destruction in collagen-induced arthritis in mice","volume":"48","author":"Burke","year":"2003","journal-title":"Arthritis Rheum"},{"key":"13","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1016\/S0960-894X(02)00517-6","article-title":"Structure-activity relationship studies of ethyl 2-[(3-methyl-2,5-dioxo(3-pyrrolinyl))amino]-4-(trifluoromethyl)pyrimidine-5-carbo xylate: an inhibitor of AP-1 and NF-kappaB mediated gene expression","volume":"12","author":"Spooner","year":"2002","journal-title":"Bioorg Med Chem Lett"},{"key":"14","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1124\/jpet.105.097584","article-title":"A selective small molecule IkappaB Kinase beta inhibitor blocks nuclear factor kappaB-mediated inflammatory responses in human fibroblast-like synoviocytes, chondrocytes, and mast cells","volume":"317","author":"Jaffee","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"15","doi-asserted-by":"crossref","first-page":"32861","DOI":"10.1074\/jbc.M211439200","article-title":"A selective IKK-2 inhibitor blocks NF-kappa B-dependent gene expression in interleukin-1 beta-stimulated synovial fibroblasts","volume":"278","author":"Hanau","year":"2003","journal-title":"J Biol Chem"},{"key":"16","first-page":"5751","article-title":"CHS 828, a novel pyridyl cyanoguanidine with potent antitumor activity in vitro and in vivo","volume":"59","author":"Binderup","year":"1999","journal-title":"Cancer Res"},{"key":"17","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/ijc.20255","article-title":"Anticancer agent CHS 828 suppresses nuclear factor-kappa B activity in cancer cells through downregulation of IKK activity","volume":"111","author":"Madsen","year":"2004","journal-title":"Int J Cancer"},{"key":"18","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4155\/ppa.13.31","article-title":"Small-molecule inhibitors of IkappaB kinase (IKK) and IKK-related kinases","volume":"2","author":"Mackay","year":"2013","journal-title":"Pharm Pat Anal"},{"key":"19","unstructured":"SAR113945 CTwf. U.S. National Institutes of Health. < http:\/\/clinicaltrialsgov\/ct2\/results?term=SAR113945&Search=Search>"},{"key":"20","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1124\/mol.107.041251","article-title":"Benzoxathiole derivative blocks lipopolysaccharide-induced nuclear factor-kappaB activation and nuclear factor-kappaB-regulated gene transcription through inactivating inhibitory kappaB kinase beta","volume":"73","author":"Kim","year":"2008","journal-title":"Mol Pharmacol"},{"key":"21","doi-asserted-by":"crossref","first-page":"36062","DOI":"10.1074\/jbc.M007204200","article-title":"Inhibition of NF-kappa B activation by arsenite through reaction with a critical cysteine in the activation loop of Ikappa B kinase","volume":"275","author":"Karin","year":"2000","journal-title":"J Biol Chem"},{"key":"22","unstructured":"COSMIC. http:\/\/cancersangeracuk\/cosmic\/search?q=IkBkB&x=11&y=11."},{"key":"23","doi-asserted-by":"crossref","first-page":"9141","DOI":"10.1021\/bi401368r","article-title":"Mutation of nonessential cysteines shows that the NF-kappaB essential modulator forms a constitutive noncovalent dimer that binds IkappaB kinase-beta with high affinity","volume":"52","author":"Whitty","year":"2013","journal-title":"Biochemistry"},{"key":"24","doi-asserted-by":"crossref","first-page":"e1001581","DOI":"10.1371\/journal.pbio.1001581","article-title":"A structural basis for IkappaB kinase 2 activation via oligomerization-dependent trans auto-phosphorylation","volume":"11","author":"Huxford","year":"2013","journal-title":"PLoS Biol"},{"key":"25","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1056\/NEJMoa1309199","article-title":"Deficiency of innate and acquired immunity caused by an IKBKB mutation","volume":"369","author":"Rump","year":"2013","journal-title":"N Engl J Med"},{"key":"26","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1074\/jbc.M511878200","article-title":"Binding of manumycin A inhibits IkappaB kinase beta activity","volume":"281","author":"Kole","year":"2006","journal-title":"J Biol Chem"},{"key":"27","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.1158\/0008-5472.CAN-08-0511","article-title":"Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis","volume":"68","author":"Aggarwal","year":"2008","journal-title":"Cancer Res"},{"key":"28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/47520","article-title":"Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase","volume":"403","author":"Santoro","year":"2000","journal-title":"Nature"},{"key":"29","doi-asserted-by":"crossref","first-page":"35764","DOI":"10.1074\/jbc.M607160200","article-title":"Triterpenoid CDDO-Me blocks the NF-kappaB pathway by direct inhibition of IKKbeta on Cys-179","volume":"281","author":"Kufe","year":"2006","journal-title":"J Biol Chem"},{"issue":"2","key":"30","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1021\/cb3005269","article-title":"Diverse functional roles of reactive cysteines","volume":"8","author":"Weerapana","year":"2013","journal-title":"ACS Chem Biol"},{"key":"31","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1074\/jbc.R111.275578","article-title":"Analysis and functional prediction of reactive cysteine residues","volume":"287","author":"Gladyshev","year":"2012","journal-title":"J Biol Chem"},{"key":"32","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1021\/cr300163e","article-title":"Cysteine-mediated redox signaling: chemistry, biology, and tools for discovery","volume":"113","author":"Carroll","year":"2013","journal-title":"Chem Rev"},{"key":"33","doi-asserted-by":"crossref","first-page":"6783","DOI":"10.4049\/jimmunol.165.12.6783","article-title":"CD4+ Th1 and CD8+ type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity","volume":"165","author":"Sauder","year":"2000","journal-title":"J Immunol"},{"key":"34","doi-asserted-by":"crossref","first-page":"17340","DOI":"10.1074\/jbc.M700890200","article-title":"Butein, a tetrahydroxychalcone, inhibits nuclear factor (NF)-kappaB and NF-kappaB-regulated gene expression through direct inhibition of IkappaBalpha kinase beta on cysteine 179 residue","volume":"282","author":"Aggarwal","year":"2007","journal-title":"J Biol Chem"},{"key":"35","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.pep.2010.02.009","article-title":"Expression, purification and functional characterization of IkappaB kinase-2 (IKK-2) mutants","volume":"72","author":"Mbalaviele","year":"2010","journal-title":"Protein Expr Purif"},{"key":"36","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1371\/journal.pmed.0020073","article-title":"Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain","volume":"2","author":"Varmus","year":"2005","journal-title":"PLoS Med"},{"issue":"8","key":"37","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1056\/NEJMoa044238","article-title":"EGFR mutation and resistance of non-small-cell lung cancer to gefitinib","volume":"352","author":"Halmos","year":"2005","journal-title":"N Engl J Med"},{"key":"38","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/nature08622","article-title":"Novel mutant-selective EGFR kinase inhibitors against EGFR T790M","volume":"462","author":"Eck","year":"2009","journal-title":"Nature"},{"key":"39","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1182\/blood-2014-04-571265","article-title":"A nonsense mutation in IKBKB causes combined immunodeficiency","volume":"124","author":"Zhong","year":"2014","journal-title":"Blood"},{"key":"40","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jaci.2013.12.1093","article-title":"Immunodeficiency and disseminated mycobacterial infection associated with homozygous nonsense mutation of IKKbeta","volume":"134","author":"Gilmour","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"41","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1007\/s10875-014-0097-1","article-title":"Immunodeficiency associated with a nonsense mutation of IKBKB","volume":"34","author":"Barington","year":"2014","journal-title":"J Clin Immunol"},{"key":"42","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood-2008-04-151944","article-title":"Modification of the cysteine residues in IkappaBalpha kinase and NF-kappaB (p65) by xanthohumol leads to suppression of NF-kappaB-regulated gene products and potentiation of apoptosis in leukemia cells","volume":"113","author":"Aggarwal","year":"2009","journal-title":"Blood"},{"key":"43","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1021\/bi900660f","article-title":"N-tosyl-L-phenylalanine chloromethyl ketone inhibits NF-kappaB activation by blocking specific cysteine residues of IkappaB kinase beta and p65\/RelA","volume":"48","author":"Jue","year":"2009","journal-title":"Biochemistry"},{"key":"44","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.bcp.2006.07.023","article-title":"Can NF-kappaB be a target for novel and efficient anti-cancer agents?","volume":"72","author":"Bours","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"45","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.intimp.2010.02.002","article-title":"Xanthohumol inhibits IL-12 production and reduces chronic allergic contact dermatitis","volume":"10","author":"Kang","year":"2010","journal-title":"Int Immunopharmacol"},{"key":"46","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejphar.2008.07.056","article-title":"Treatment with N-tosyl-l-phenylalanine chloromethyl ketone after the onset of collagen-induced arthritis reduces joint erosion and NF-kappaB activation","volume":"595","author":"Jue","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"47","first-page":"292","article-title":"Conversion from the \u201concogene addiction\u201d to \u201cdrug addiction\u201d by intensive inhibition of the EGFR and MET in lung cancer with activating EGFR mutation","volume":"76","author":"Mitsudomi","year":"2011","journal-title":"Lung Cancer"},{"key":"48","doi-asserted-by":"crossref","first-page":"e41017","DOI":"10.1371\/journal.pone.0041017","article-title":"Loss of activating EGFR mutant gene contributes to acquired resistance to EGFR tyrosine kinase inhibitors in lung cancer cells","volume":"7","author":"Arao","year":"2012","journal-title":"PLoS One"},{"key":"49","first-page":"176","article-title":"Clinical and molecular evidences of epithelial to mesenchymal transition in acquired resistance to EGFR-TKIs","volume":"73","author":"Lee","year":"2010","journal-title":"Lung Cancer"},{"key":"50","doi-asserted-by":"crossref","first-page":"7519","DOI":"10.1158\/1078-0432.CCR-08-0151","article-title":"Acquired resistance to epidermal growth factor receptor kinase inhibitors associated with a novel T854A mutation in a patient with EGFR-mutant lung adenocarcinoma","volume":"14","author":"Pao","year":"2008","journal-title":"Clin Cancer Res"},{"key":"51","doi-asserted-by":"crossref","first-page":"6522","DOI":"10.1038\/ncomms7522","article-title":"Ainsliadimer A selectively inhibits IKKalpha\/beta by covalently binding a conserved cysteine","volume":"6","author":"Lei","year":"2015","journal-title":"Nat Commun"},{"key":"52","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1124\/jpet.107.122671","article-title":"Dihydrocucurbitacin B inhibits delayed type hypersensitivity reactions by suppressing lymphocyte proliferation","volume":"322","author":"Rios","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"53","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1172\/JCI29463","article-title":"Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts","volume":"116","author":"Carmeliet","year":"2006","journal-title":"J Clin Invest"},{"key":"54","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.bbrc.2008.08.153","article-title":"Sinomenine ameliorates arthritis via MMPs, TIMPs, and cytokines in rats","volume":"376","author":"Liu","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"55","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nature09853","article-title":"Crystal structure of inhibitor of kappaB kinase beta","volume":"472","author":"Wu","year":"2011","journal-title":"Nature"},{"key":"56","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/jcb.22126","article-title":"Mechanistic study of saikosaponin-d (Ssd) on suppression of murine T lymphocyte activation","volume":"107","author":"Liu","year":"2009","journal-title":"J Cell Biochem"},{"key":"57","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1124\/mol.107.035212","article-title":"UR-1505, a new salicylate, blocks T cell activation through nuclear factor of activated T cells","volume":"72","author":"Ramis","year":"2007","journal-title":"Mol Pharmacol"},{"key":"58","first-page":"605","article-title":"Simvastatin inhibits T-cell activation by selectively impairing the function of Ras superfamily GTPases","volume":"19","author":"Baldari","year":"2005","journal-title":"FASEB J"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5567","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T17:07:56Z","timestamp":1589389676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,10]]},"references-count":58,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2015,10,13]]}},"alternative-id":["5567","26378659"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.5567","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,10]]}}}